Ibiglustat (Venglustat) | Glucosylceramide Synthase Inhibitor | MedChemExpress
Ibiglustat (Venglustat) is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease. For research use only. We do not sell to patients. Ibiglustat Chemical Structure CAS No. : 1401090-53-6 Get it by tomorrow June 10 for select sizes. Order within 0 hrs 28 mins. This product is a controlled substance and not for sale in your territory. Based on 3 publication(s) in Google Scholar Human, Mouse WB, IHC-P, IP Ibiglustat (Venglustat) is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease[1][2]. Glucosylceramide synthase[1]. Ibiglustat (SAR402671) (1 μ
Explore this link on the map →